<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07629999031678</udiDi>
    <basicUdiDi>7649994728lipivir0001CG</basicUdiDi>
    <tradeName>lipivir(R)</tradeName>
    <deviceName>lipivir(R)</deviceName>
    <manufacturerName>Devirex AG</manufacturerName>
    <manufacturerSrn>CH-MF-000017711</manufacturerSrn>
    <authorisedRepresentativeName>Stefan Gangkofner</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005777</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M04041503</emdnCode>
    <emdnDescription>DRESSINGS IN SOLUTIONS, EMULSIONS, GELS, POWDERS WITH SYNTHETIC COMPONENTS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7629999031678</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:48:36.636Z</lastUpdated>
  </row>
  <row>
    <udiDi>07629999031685</udiDi>
    <basicUdiDi>7649994728lipivir0001CG</basicUdiDi>
    <tradeName>lipivir</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Devirex AG</manufacturerName>
    <manufacturerSrn>CH-MF-000017711</manufacturerSrn>
    <authorisedRepresentativeName>Stefan Gangkofner</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005777</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M04041503</emdnCode>
    <emdnDescription>DRESSINGS IN SOLUTIONS, EMULSIONS, GELS, POWDERS WITH SYNTHETIC COMPONENTS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7629999031685</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T06:11:06.534Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649994728014</udiDi>
    <basicUdiDi>7649994728lipivir0001CG</basicUdiDi>
    <tradeName>lipivir(R)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Devirex AG</manufacturerName>
    <manufacturerSrn>CH-MF-000017711</manufacturerSrn>
    <authorisedRepresentativeName>Stefan Gangkofner</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005777</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M04041503</emdnCode>
    <emdnDescription>DRESSINGS IN SOLUTIONS, EMULSIONS, GELS, POWDERS WITH SYNTHETIC COMPONENTS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7649994728014</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:48:14.505Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649994728113</udiDi>
    <basicUdiDi>7649994728lipivir0001CG</basicUdiDi>
    <tradeName>lipivir(R)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Devirex AG</manufacturerName>
    <manufacturerSrn>CH-MF-000017711</manufacturerSrn>
    <authorisedRepresentativeName>Stefan Gangkofner</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005777</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M04041503</emdnCode>
    <emdnDescription>DRESSINGS IN SOLUTIONS, EMULSIONS, GELS, POWDERS WITH SYNTHETIC COMPONENTS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>7649994728113</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:48:04.357Z</lastUpdated>
  </row>
</eudamedExport>